Long-term Beta-blocker Therapy After Acute Myocardial Infarction

PHASE4RecruitingINTERVENTIONAL
Enrollment

2,540

Participants

Timeline

Start Date

May 4, 2021

Primary Completion Date

October 30, 2025

Study Completion Date

March 31, 2026

Conditions
Myocardial Infarction
Interventions
DRUG

Discontinuation of β-blocker

Discontinuation of β-blocker after at least 1 year of β-blocker therapy after acute myocardial infarction

Trial Locations (1)

06351

RECRUITING

Samsung Medical Center, Seoul

All Listed Sponsors
collaborator

Kangbuk Samsung Hospital

OTHER

collaborator

Gyeongsang National University Hospital

OTHER

collaborator

Kyung Hee University Hospital

OTHER

collaborator

Keimyung University Dongsan Medical Center

OTHER

collaborator

Korea University Anam Hospital

OTHER

collaborator

Sejong General Hospital

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Samsung Changwon Hospital

OTHER

collaborator

Saint Vincent's Hospital, Korea

OTHER

collaborator

Presbyterian medical center

UNKNOWN

collaborator

Wonkwang University Hospital

OTHER

collaborator

Wonju Severance Christian Hospital

OTHER

collaborator

Ewha Womans University Seoul Hospital

OTHER

collaborator

Inje University Ilsan Paik Hospital

OTHER

collaborator

Chonbuk National University Hospital

OTHER

collaborator

Chonnam National University Hospital

OTHER

collaborator

Jeju National University Hospital

OTHER

collaborator

Chosun University Hospital

OTHER

collaborator

Chungbuk National University Hospital

OTHER

collaborator

Chungnam National University Hospital

OTHER

lead

Samsung Medical Center

OTHER